Post-earnings recap
Reported
Tue, Feb 19, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Medtronic's earnings report showed a slight beat on EPS, which led to a modest increase in stock price. The lack of revenue data and guidance may leave investors cautious. The positive sentiment from management about innovation suggests potential for future growth, but uncertainty remains without specific forecasts.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.29 | N/A | +1.43% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their product developments. However, they did not provide specific guidance for future quarters.
Management expressed confidence in the company's ongoing product pipeline.
They highlighted the importance of innovation in driving future growth.
Est. EPS
—
Est. Rev
—
Impl. Move
—